Edition:
United Kingdom

Luye Pharma Group Ltd (2186.HK)

2186.HK on Hong Kong Stock

6.96HKD
20 Feb 2018
Change (% chg)

HK$0.31 (+4.66%)
Prev Close
HK$6.65
Open
HK$6.68
Day's High
HK$7.12
Day's Low
HK$6.68
Volume
17,263,500
Avg. Vol
20,396,830
52-wk High
HK$7.40
52-wk Low
HK$3.95

Select another date:

Thu, Feb 8 2018

BRIEF-Luye Pharma Group's Drug Approved By U.S. FDA

* ‍GROUP'S DRUG ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION HAS BEEN APPROVED BY U.S. FDA

BRIEF-Luye Pharma ‍Updates On Development Of Ansofaxine Hydrochloride Extended Release Tablets​

* ‍UPDATES ON PHASE II CLINICAL TRIAL IN CHINA FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS​

BRIEF-Luye Pharma Group‍ Announces Update on Patent Litigation Regarding Rivastigmine 1 Day Patch

* COURT OF APPEAL FOR DISTRICT OF MUNICH, GERMANY DISMISSES APPEAL FROM NOVARTIS AG AS CLAIMANT IN PATENT INFRINGEMENT LAWSUIT

BRIEF-Luye Pharma Says ‍Unit Applies To Register For Proposed Issue Of Debt Securities

* ‍UNIT APPLIES TO NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS TO REGISTER FOR PROPOSED ISSUE OF DEBT SECURITIES

BRIEF-Luye Pharma repurchases 6.6 mln shares

* Repurchased 6.6 million ordinary shares of company Source text for Eikon: Further company coverage:

BRIEF-Luye Pharma Group says HY profit attributable fell 9.2 pct

* HY profit attributable to shareholders fell 9.2 pct to RMB385.4 million

Select another date: